Screener
Harmony Biosciences Holdings, Inc. HRMY Equity Method Investments
Equity Method Investments at other companies
Other financials
Where this comes from
Reported directly by Harmony Biosciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermInvestments.
The source filing: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 8:16 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056720
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Other current assets | 7,595 | 13,516 |
| Total current assets | 778,817 | 907,014 |
| NONCURRENT ASSETS: | ||
| Investments, long-term | 229,555 | 107,127 |
| Intangible assets, net | 83,457 | 89,418 |
| Deferred tax asset | 153,562 | 149,699 |
| Other noncurrent assets | 26,433 | 18,373 |
| Total noncurrent assets | 493,007 | 364,617 |
Item 1. Financial Statements
FAQ
- What is Harmony Biosciences Holdings, Inc.'s equity method investments?
- Harmony Biosciences Holdings, Inc. (HRMY) reported equity method investments of $229.56M in Q1 2026.
- How has Harmony Biosciences Holdings, Inc.'s equity method investments changed year-over-year?
- Harmony Biosciences Holdings, Inc.'s equity method investments increased by 122.3% year-over-year, from $103.25M to $229.56M.
- What is the long-term trend for Harmony Biosciences Holdings, Inc.'s equity method investments?
- Over 3 years (2022 to 2025), Harmony Biosciences Holdings, Inc.'s equity method investments has grown at a 68.1% compound annual growth rate (CAGR), from $22.57M to $107.13M.
- What does equity method investments mean?
- Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.
Ask your AI about Harmony Biosciences Holdings, Inc.'s equity method investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude